| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
| filingDate |
2005-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101130913-B1 |
| titleOfInvention |
Heterocyclic Compounds and Anti-Malignant Tumors Comprising the Same as Active Ingredients |
| abstract |
An anti-malignant tumor agent which contains the heterocyclic compound and heterocyclic compound represented by following formula (I) as an active ingredient:n n n n n n n n Wherein X represents a nitrogen atom or CH; Y represents C 1 -C 6 alkyl; R 1 represents morpholino (which may be substituted by 1 to 4 C 1 -C 6 alkyl); R 2 and R 3 each represent a hydrogen atom or C 1 -C 6 alkyl. |
| priorityDate |
2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |